183 related articles for article (PubMed ID: 34743509)
1. Noncovalent Theranostic Prodrug for Hypoxia-Activated Drug Delivery and Real-Time Tracking.
Zhao XB; Gao K; Shi YP
Anal Chem; 2021 Nov; 93(45):15080-15087. PubMed ID: 34743509
[TBL] [Abstract][Full Text] [Related]
2. Theranostic Heterodimeric Prodrug with Dual-Channel Fluorescence Turn-On and Dual-Prodrug Activation for Synergistic Cancer Therapy.
Jiang M; Wang K; Xiao X; Zong Q; Zheng R; Yuan Y
Adv Healthc Mater; 2021 Nov; 10(21):e2101144. PubMed ID: 34453773
[TBL] [Abstract][Full Text] [Related]
3. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
Wang Z; Wu H; Liu P; Zeng F; Wu S
Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
[TBL] [Abstract][Full Text] [Related]
4. A light-activatable theranostic combination for ratiometric hypoxia imaging and oxygen-deprived drug activity enhancement.
Ge L; Tang Y; Wang C; Chen J; Mao H; Jiang X
Nat Commun; 2024 Jan; 15(1):153. PubMed ID: 38167737
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional Theranostic Liposomes Loaded with a Hypoxia-Activated Prodrug for Cascade-Activated Tumor Selective Combination Therapy.
Dai Y; Wang B; Sun Z; Cheng J; Zhao H; Wu K; Sun P; Shen Q; Li M; Fan Q
ACS Appl Mater Interfaces; 2019 Oct; 11(43):39410-39423. PubMed ID: 31578854
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug.
Wu X; Sun X; Guo Z; Tang J; Shen Y; James TD; Tian H; Zhu W
J Am Chem Soc; 2014 Mar; 136(9):3579-88. PubMed ID: 24524232
[TBL] [Abstract][Full Text] [Related]
7. Precisely Traceable Drug Delivery of Azoreductase-Responsive Prodrug for Colon Targeting via Multimodal Imaging.
Zhao XB; Ha W; Gao K; Shi YP
Anal Chem; 2020 Jul; 92(13):9039-9047. PubMed ID: 32501673
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory-stimuli-responsive turn-on NIR fluorogenic theranostic prodrug: adjuvant delivery of diclofenac and hydrogen sulfide attenuates acute inflammatory disorders.
Sufian A; Parihar N; Badirujjaman M; Barman P; Kesarwani R; Pemmaraju DB; Bhabak KP
J Mater Chem B; 2024 May; 12(17):4248-4261. PubMed ID: 38602387
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-Activated Anticancer Prodrug for Bioimaging, Tracking Drug Release, and Anticancer Application.
Liu W; Liu H; Peng X; Zhou G; Liu D; Li S; Zhang J; Wang S
Bioconjug Chem; 2018 Oct; 29(10):3332-3343. PubMed ID: 30192132
[TBL] [Abstract][Full Text] [Related]
10. GSH-Activated NIR Fluorescent Prodrug for Podophyllotoxin Delivery.
Liu Y; Zhu S; Gu K; Guo Z; Huang X; Wang M; Amin HM; Zhu W; Shi P
ACS Appl Mater Interfaces; 2017 Sep; 9(35):29496-29504. PubMed ID: 28758393
[TBL] [Abstract][Full Text] [Related]
11.
Dong Y; Du P; Liu P
Int J Pharm; 2020 Oct; 588():119723. PubMed ID: 32755688
[TBL] [Abstract][Full Text] [Related]
12. Real-Time Multi-Photon Tracking and Bioimaging of Glycosylated Theranostic Prodrugs upon Specific Enzyme Triggered Release.
Calatrava-Pérez E; Marchetti LA; McManus GJ; Lynch DM; Elmes RBP; Williams DC; Gunnlaugsson T; Scanlan EM
Chemistry; 2022 Jan; 28(3):e202103858. PubMed ID: 34820925
[TBL] [Abstract][Full Text] [Related]
13. Photoinduced Electron Transfer-Based Glutathione-Sensing Theranostic Nanoprodrug with Self-Tracking and Real-Time Drug Release Monitoring for Cancer Treatment.
Nisar S; Starosta E; Elayyan M; Regmi A; Sui B
ACS Appl Mater Interfaces; 2024 Feb; 16(6):6859-6867. PubMed ID: 38299497
[TBL] [Abstract][Full Text] [Related]
14. NIR Fluorogenic Dye as a Modular Platform for Prodrug Assembly: Real-Time in vivo Monitoring of Drug Release.
Redy-Keisar O; Ferber S; Satchi-Fainaro R; Shabat D
ChemMedChem; 2015 Jun; 10(6):999-1007. PubMed ID: 25847527
[TBL] [Abstract][Full Text] [Related]
15. Direct Readout Hypoxia Tumor Suppression In Vivo through NIR-Theranostic Activation.
Zhao YQ; Biswas S; Chen Q; Jia M; Zhou Y; Bhuniya S
ACS Appl Bio Mater; 2021 Jul; 4(7):5686-5694. PubMed ID: 35006742
[TBL] [Abstract][Full Text] [Related]
16. A Glutathione (GSH)-Responsive Near-Infrared (NIR) Theranostic Prodrug for Cancer Therapy and Imaging.
Kong F; Liang Z; Luan D; Liu X; Xu K; Tang B
Anal Chem; 2016 Jun; 88(12):6450-6. PubMed ID: 27216623
[TBL] [Abstract][Full Text] [Related]
17. A theranostic prodrug based on FRET for real-time drug release monitoring in response to biothiols.
Hu Y; Zeng F
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():77-85. PubMed ID: 28024642
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-Activated and Indomethacin-Mediated Theranostic Prodrug Releasing Drug On-Demand for Tumor Imaging and Therapy.
Peng X; Gao J; Yuan Y; Liu H; Lei W; Li S; Zhang J; Wang S
Bioconjug Chem; 2019 Nov; 30(11):2828-2843. PubMed ID: 31592652
[TBL] [Abstract][Full Text] [Related]
19. Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy.
Feng L; Cheng L; Dong Z; Tao D; Barnhart TE; Cai W; Chen M; Liu Z
ACS Nano; 2017 Jan; 11(1):927-937. PubMed ID: 28027442
[TBL] [Abstract][Full Text] [Related]
20. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.
Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R
Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
